Published Papers & Misc - MIYAZAKI Yasunari

81. Ikeda T, Ichiba S, Sasaki T, Sato M, Konoeda C, Okamoto T, Miyazaki Y, Nakajima J, Sakamoto A. A case of severe respiratory failure due to interstitial pneumonia successfully bridged to lung transplantation from a brain-dead donor using 109-day veno-arterial extracorporeal membrane oxygenation. Journal of artificial organs : the official journal of the Japanese Society for Artificial Organs. 2022.06; 26 (1): 84-88. ( PubMed, DOI )

82. Kawamoto Y, Yatomi Y, Furusawa H, Hanzawa S, Miyazaki Y, Tanaka M. Understanding the process of people with hypersensitivity pneumonitis implementing continuous antigen avoidance and their affecting situations: A grounded theory study. Journal of clinical nursing. 2022.06; 32 (11-12): 2880-2891. ( PubMed, DOI )

83. Yuko Kawamoto, Yumiko Yatomi, Haruhiko Furusawa, Satoshi Hanzawa, Yasunari Miyazaki, Makoto Tanaka. Understanding the process of people with hypersensitivity pneumonitis Implementing continuous antigen avoidance and their affecting situations: A grounded theory study. Journal of Clinical Nursing. 2022.06; 1-12. ( DOI )

84. Mitsumura T, Okamoto T, Tosaka M, Yamana T, Shimada S, Iijima Y, Sakakibara R, Shibata S, Honda T, Shirai T, Ishizuka M, Aiboshi J, Furusawa H, Tateishi T, Tamaoka M, Shigemitsu H, Arai H, Otomo Y, Tohda S, Anzai T, Takahashi K, Yasuda S, Miyazaki Y. SARS-CoV-2 RNA copy number is a factor associated with the mortality of COVID-19 and improves the predictive performance of mortality in severe cases. Japanese journal of infectious diseases. 2022.05; 75 (5): 504-510. ( PubMed, DOI )

85. Ejima Masaru, Okamoto Tsukasa, Suzuki Takafumi, Miyazaki Yasunari. Role of serum surfactant protein-D as a prognostic predictor in fibrotic hypersensitivity pneumonitis(タイトル和訳中) Respiratory Investigation. 2022.05; 60 (3): 369-378. ( ichushi )

86. Endo S, Honda T, Kawahara T, Sakakibara R, Mitsumura T, Okamoto T, Miyazaki Y. Profile of metastatic lung cancer patients susceptible to development of thromboembolism during immunotherapy. Cancer treatment and research communications. 2022.03; 31 100547. ( PubMed, DOI )

87. Sakashita H, Uchibori K, Jin Y, Tsutsui T, Honda T, Sakakibara R, Mitsumura T, Nukui Y, Shirai T, Masuo M, Suhara K, Furusawa H, Yamashita T, Ohba T, Saito K, Takagiwa J, Miyashita Y, Inase N, Miyazaki Y. A phase II feasibility study of carboplatin and nab-paclitaxel for advanced non-small cell lung cancer patients with interstitial lung disease (YLOG0114). Thoracic cancer. 2022.03; 13 (9): 1267-1275. ( PubMed, DOI )

88. Ejima M, Okamoto T, Suzuki T, Miyazaki Y. Role of serum surfactant protein-D as a prognostic predictor in fibrotic hypersensitivity pneumonitis. Respiratory investigation. 2022.01; 60 (3): 369-378. ( PubMed, DOI )

89. Murakami T, Iijima Y, Ando T, Ejima M, Shirai T, Furusawa H, Okamoto T, Tateishi T, Tamaoka M, Miyazaki Y. Successful diagnosis of humidifier lung by individual provocation test to a responsible environment, a case report. Respiratory medicine case reports. 2022; 37 101639. ( PubMed, DOI )

90. Suzuki Takafumi, Okamoto Tsukasa, Akiyama Masako, Honda Takayuki, Ejima Masaru, Ishizuka Masahiro, Sakashita Hiroyuki, Miyazaki Yasunari. Cumulative Incidences of Lung Cancer in Various Interstitial Lung Diseases(タイトル和訳中) Journal of Medical and Dental Sciences. 2022; 69 11-19. ( ichushi )

91. Kubota-Miyazawa Ayako, Sugimoto Kumiko, Miyazaki Yasunari, Sakurai Yoshimi, Oki Meiko, Suzuki Hitomi, Yoshida Naomi. A cross-sectional survey on the status of oral health administration for students in Japanese universities(タイトル和訳中) Journal of Medical and Dental Sciences. 2022; 69 21-28. ( ichushi )

92. Shimada S, Nakai R, Aoki K, Kudoh S, Imura S, Shimoeda N, Ohno G, Watanabe K, Miyazaki Y, Ishii Y, Tateda K. Characterization of the First Cultured Psychrotolerant Representative of <i>Legionella</i> from Antarctica Reveals Its Unique Genome Structure. Microbiology spectrum. 2021.10; 9 (2): e0042421. ( PubMed, DOI )

93. Arai Teppei, Umeyama Takashi, Majima Hidetaka, Inukai Tatsuya, Watanabe Akira, Miyazaki Yoshitsugu, Kamei Katsuhiko. Hmg1 mutations in Aspergillus fumigatus and their contribution to triazole susceptibility MEDICAL MYCOLOGY. 2021.10; 59 (10): 980-984. ( DOI )

94. Majima Hidetaka, Arai Teppei, Kusuya Yoko, Takahashi Hiroki, Watanabe Akira, Miyazaki Yasunari, Kamei Katsuhiko. Genetic differences between Japan and other countries in cyp51A polymorphisms of Aspergillus fumigatus MYCOSES. 2021.09; 64 (11): 1354-1365. ( PubMed, DOI )

95. Shindo Y, Kondoh Y, Kada A, Doi Y, Tomii K, Mukae H, Murata N, Imai R, Okamoto M, Yamano Y, Miyazaki Y, Shinoda M, Aso H, Izumi S, Ishii H, Ito R, Saito AM, Saito TI, Hasegawa Y. Phase II Clinical Trial of Combination Therapy with Favipiravir and Methylprednisolone for COVID-19 with Non-Critical Respiratory Failure. Infectious diseases and therapy. 2021.08; 10 (4): 2353-2369. ( PubMed, DOI )

96. Katayanagi S, Setoguchi Y, Kitagawa S, Okamoto T, Miyazaki Y. Alternative gene expression by TOLLIP variant is associated with lung function in chronic hypersensitivity pneumonitis. Chest. 2021.08; 161 (2): 458-469. ( PubMed, DOI )

97. Mitsumura Takahiro, Kumaki Yuichi, Takahashi Kenta, Matsudera Shotaro, Sakakibara Rie, Honda Takayuki, Ishizuka Masahiro, Iijima Yuki, Shirai Tsuyoshi, Okamoto Tsukasa, Tateishi Tomoya, Sakashita Hiroyuki, Miyake Satoshi, Ikeda Sadakatsu, Miyazaki Yasunari. Treatment of advanced lung cancer based on genomic profiling using liquid biopsy (plasma): A review of three cases THORACIC CANCER. 2021.08; 12 (18): 2508-2512. ( PubMed, DOI )

98. Ejima Masaru, Okamoto Tsukasa, Suzuki Takafumi, Anzai Tatsuhiko, Takahashi Kunihiko, Miyazaki Yasunari. Efficacy of treatment with corticosteroids for fibrotic hypersensitivity pneumonitis: a propensity score-matched cohort analysis BMC PULMONARY MEDICINE. 2021.07; 21 (1): 243. ( PubMed, DOI )

99. Komatsu M, Yamamoto H, Matsui S, Terasaki Y, Hebisawa A, Iwasawa T, Johkoh T, Baba T, Miyamoto A, Handa T, Tomii K, Waseda Y, Bando M, Ishii H, Miyazaki Y, Yoshizawa A, Takemura T, Kawabata Y, Ogura T. Clinical characteristics of immunoglobulin G₄-positive interstitial pneumonia. ERJ open research. 2021.07; 7 (3): ( PubMed, DOI )

100. Mitsumura Takahiro, Okamoto Tsukasa, Shirai Tsuyoshi, Iijima Yuki, Sakakibara Rie, Honda Takayuki, Ishizuka Masahiro, Aiboshi Junichi, Tateishi Tomoya, Tamaoka Meiyo, Shigemitsu Hidenobu, Arai Hirokuni, Otomo Yasuhiro, Tohda Shuji, Anzai Tatsuhiko, Takahashi Kunihiko, Yasuda Shinsuke, Miyazaki Yasunari. Predictors associated with clinical improvement of SARS-CoV-2 pneumonia(和訳中) Journal of Infection and Chemotherapy. 2021.06; 27 (6): 857-863. ( ichushi )